These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 4006154)
1. The pharmaceutical industry and academic medicine in collaboration. Wroblewski R Circulation; 1985 Aug; 72(2 Pt 2):I3-7. PubMed ID: 4006154 [No Abstract] [Full Text] [Related]
2. The pharmaceutical industry and academic medicine: opportunities for physician collaboration. Jefferis JE Circulation; 1985 Aug; 72(2 Pt 2):I21-4. PubMed ID: 3924438 [No Abstract] [Full Text] [Related]
4. Industry and academia in collaboration: the Pfizer experience. Price FD Circulation; 1985 Aug; 72(2 Pt 2):I13-7. PubMed ID: 4006152 [No Abstract] [Full Text] [Related]
5. A university administrator's view of academia--industry collaboration. Mullins CB Circulation; 1985 Aug; 72(2 Pt 2):I8-12. PubMed ID: 4006162 [No Abstract] [Full Text] [Related]
9. US academic researchers hold divided views on ties to industry. Roehr B BMJ; 2011 Jun; 342():d3883. PubMed ID: 21690167 [No Abstract] [Full Text] [Related]
10. University physician-researcher conflicts of interest: the inadequacy of current controls and proposed reform. Maatz CT High Technol Law J; 1992; 7():137-88. PubMed ID: 11659962 [No Abstract] [Full Text] [Related]
12. Academic-industrial relations in the United Kingdom. Dollery CT Circulation; 1985 Aug; 72(2 Pt 2):I51-2. PubMed ID: 4006160 [No Abstract] [Full Text] [Related]
13. The role and responsibility of industry in research. Lasagna L Dolentium Hominum; 1987; 4(2nd Yr. 1):56-9. PubMed ID: 11653199 [No Abstract] [Full Text] [Related]
14. Drug discovery: new models for industry-academic partnerships. Tralau-Stewart CJ; Wyatt CA; Kleyn DE; Ayad A Drug Discov Today; 2009 Jan; 14(1-2):95-101. PubMed ID: 18992364 [TBL] [Abstract][Full Text] [Related]
15. Public-private partnerships in biomedical research: resolving conflicts arising under the Federal Technology Transfer Act of 1986. Bulleit TN J Law Health; 1989-1990; 4(1):1-20. PubMed ID: 11652568 [No Abstract] [Full Text] [Related]
16. In search of funding: the clinical investigator and the drug company; Commentary: why researchers need not be demoralized. Siris ES; Burrell CD IRB; 1983; 5(6):1-5. PubMed ID: 11649526 [No Abstract] [Full Text] [Related]
17. Institutional review boards in the university setting: review of pharmaceutical testing protocols, informed consent and ethical concerns. Kobasic DM J Coll Univ Law; 1988; 15(2):185-216. PubMed ID: 11659168 [No Abstract] [Full Text] [Related]
18. Money is putting people at risk in biomedical research. Andrews LB Chron High Educ; 2000 Mar; 46(27):B1, B4-5. PubMed ID: 11657699 [No Abstract] [Full Text] [Related]
19. Wellcome and Zeneca form genetic alliance. Dickson D Nature; 1995 Jul; 376(6535):9. PubMed ID: 7596442 [No Abstract] [Full Text] [Related]
20. Policy directions for the National Heart, Lung, and Blood Institute: implications for academia and industry. Lenfant C Circulation; 1985 Aug; 72(2 Pt 2):I44-7. PubMed ID: 4006158 [No Abstract] [Full Text] [Related] [Next] [New Search]